Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156What this trial is testingUpadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating MutationsWho this might be right forJAK1 GOFSTAT1 GOFSTAT3 GOF+2 more Lisa Satter 30